Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
Current Portion of Long-Term Debt
Fusion Antibodies PLC
Current Portion of Long-Term Debt Peer Comparison
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fusion Antibodies PLC
LSE:FAB
|
Current Portion of Long-Term Debt
£17k
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Current Portion of Long-Term Debt
£4.3m
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Current Portion of Long-Term Debt
£826k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Diaceutics PLC
LSE:DXRX
|
Current Portion of Long-Term Debt
£124k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
Ergomed PLC
LSE:ERGO
|
Current Portion of Long-Term Debt
£1.6m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
170%
|
CAGR 10-Years
N/A
|
|
hVIVO PLC
LSE:HVO
|
Current Portion of Long-Term Debt
£367k
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
1%
|
See Also
What is Fusion Antibodies PLC's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
17k
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Current Portion of Long-Term Debt amounts to 17k GBP.
What is Fusion Antibodies PLC's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
-13%
Over the last year, the Current Portion of Long-Term Debt growth was -80%. The average annual Current Portion of Long-Term Debt growth rates for Fusion Antibodies PLC have been -53% over the past three years , -13% over the past five years .